593 related articles for article (PubMed ID: 24101917)
1. From antimicrobial to anticancer peptides. A review.
Gaspar D; Veiga AS; Castanho MA
Front Microbiol; 2013 Oct; 4():294. PubMed ID: 24101917
[TBL] [Abstract][Full Text] [Related]
2. Antimicrobial Peptides: Potential Application in Liver Cancer.
Zhang C; Yang M; Ericsson AC
Front Microbiol; 2019; 10():1257. PubMed ID: 31231341
[TBL] [Abstract][Full Text] [Related]
3. CancerGram: An Effective Classifier for Differentiating Anticancer from Antimicrobial Peptides.
Burdukiewicz M; Sidorczuk K; Rafacz D; Pietluch F; Bąkała M; Słowik J; Gagat P
Pharmaceutics; 2020 Oct; 12(11):. PubMed ID: 33142753
[TBL] [Abstract][Full Text] [Related]
4. Anticancer activities of natural antimicrobial peptides from animals.
Qu B; Yuan J; Liu X; Zhang S; Ma X; Lu L
Front Microbiol; 2023; 14():1321386. PubMed ID: 38298540
[TBL] [Abstract][Full Text] [Related]
5. Incorporating support vector machine with sequential minimal optimization to identify anticancer peptides.
Wan Y; Wang Z; Lee TY
BMC Bioinformatics; 2021 May; 22(1):286. PubMed ID: 34051755
[TBL] [Abstract][Full Text] [Related]
6. Peptides with Dual Antimicrobial and Anticancer Activities.
Felício MR; Silva ON; Gonçalves S; Santos NC; Franco OL
Front Chem; 2017; 5():5. PubMed ID: 28271058
[TBL] [Abstract][Full Text] [Related]
7. Anticancer Activities of Natural and Synthetic Peptides.
Hilchie AL; Hoskin DW; Power Coombs MR
Adv Exp Med Biol; 2019; 1117():131-147. PubMed ID: 30980357
[TBL] [Abstract][Full Text] [Related]
8. Exploratory data analysis of physicochemical parameters of natural antimicrobial and anticancer peptides: Unraveling the patterns and trends for the rational design of novel peptides.
Saini S; Rathore A; Sharma S; Saini A
Bioimpacts; 2024; 14(1):26438. PubMed ID: 38327633
[TBL] [Abstract][Full Text] [Related]
9. Alpha-helical cationic anticancer peptides: a promising candidate for novel anticancer drugs.
Huang Y; Feng Q; Yan Q; Hao X; Chen Y
Mini Rev Med Chem; 2015; 15(1):73-81. PubMed ID: 25382016
[TBL] [Abstract][Full Text] [Related]
10. Anticancer alpha-helical peptides and structure/function relationships underpinning their interactions with tumour cell membranes.
Dennison SR; Whittaker M; Harris F; Phoenix DA
Curr Protein Pept Sci; 2006 Dec; 7(6):487-99. PubMed ID: 17168782
[TBL] [Abstract][Full Text] [Related]
11. Correlation between the secondary structure and surface activity of β-sheet forming cationic amphiphilic peptides and their anticancer activity.
Hadianamrei R; Tomeh MA; Brown S; Wang J; Zhao X
Colloids Surf B Biointerfaces; 2022 Jan; 209(Pt 2):112165. PubMed ID: 34715505
[TBL] [Abstract][Full Text] [Related]
12. Antimicrobial/anticancer peptides: bioactive molecules and therapeutic agents.
Kardani K; Bolhassani A
Immunotherapy; 2021 Jun; 13(8):669-684. PubMed ID: 33878901
[TBL] [Abstract][Full Text] [Related]
13. Recent advances and applications of peptide-agent conjugates for targeting tumor cells.
Alamdari-Palangi V; Jaberi KR; Shahverdi M; Naeimzadeh Y; Tajbakhsh A; Khajeh S; Razban V; Fallahi J
J Cancer Res Clin Oncol; 2023 Nov; 149(16):15249-15273. PubMed ID: 37581648
[TBL] [Abstract][Full Text] [Related]
14. Mode of action of anticancer peptides (ACPs) from amphibian origin.
Oelkrug C; Hartke M; Schubert A
Anticancer Res; 2015 Feb; 35(2):635-43. PubMed ID: 25667440
[TBL] [Abstract][Full Text] [Related]
15. MDTL-ACP: Anticancer Peptides Prediction Based on Multi-Domain Transfer Learning.
Cao J; Zhou W; Yu Q; Ji J; Zhang J; He S; Zhu Z
IEEE J Biomed Health Inform; 2023 Dec; PP():. PubMed ID: 38147420
[TBL] [Abstract][Full Text] [Related]
16. G-ACP: a machine learning approach to the prediction of therapeutic peptides for gastric cancer.
Azad H; Akbar MY; Sarfraz J; Haider W; Riaz MN; Ali GM; Ghazanfar S
J Biomol Struct Dyn; 2024 Mar; ():1-14. PubMed ID: 38450672
[TBL] [Abstract][Full Text] [Related]
17. Anti-Cancer Peptides: Status and Future Prospects.
Ghaly G; Tallima H; Dabbish E; Badr ElDin N; Abd El-Rahman MK; Ibrahim MAA; Shoeib T
Molecules; 2023 Jan; 28(3):. PubMed ID: 36770815
[TBL] [Abstract][Full Text] [Related]
18. Clinical Applications and Anticancer Effects of Antimicrobial Peptides: From Bench to Bedside.
Jafari A; Babajani A; Sarrami Forooshani R; Yazdani M; Rezaei-Tavirani M
Front Oncol; 2022; 12():819563. PubMed ID: 35280755
[TBL] [Abstract][Full Text] [Related]
19. Lipopeptisomes: Anticancer peptide-assembled particles for fusolytic oncotherapy.
Aronson MR; Simonson AW; Orchard LM; Llinás M; Medina SH
Acta Biomater; 2018 Oct; 80():269-277. PubMed ID: 30240951
[TBL] [Abstract][Full Text] [Related]
20. Bioactive peptides for anticancer therapies.
Zhang Y; Wang C; Zhang W; Li X
Biomater Transl; 2023; 4(1):5-17. PubMed ID: 37206303
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
